Laddar...
Progression free survival (PFS) and toxicities of palbociclib in a geriatric population
PURPOSE: Over 40% of newly diagnosed metastatic breast cancer patients are ≥ 70 years-old however this population is less likely to be represented in clinical trials. The objective of this study was to analyze PFS, dose reductions, dose delays and toxicity in a geriatric population receiving palboci...
Sparad:
| I publikationen: | Breast Cancer Res Treat |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535110/ https://ncbi.nlm.nih.gov/pubmed/30835017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05181-4 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|